13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 1 of 5

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Tappan Street Partners 2,298,684 0 2,298,684 0 2,298,684 5.1%

Follow Prasad Phatak And Chris Koranda's Tappan Street Partners

Page 1 of 5 – SEC Filing



Washington, D.C. 20549


Under the Securities Exchange Act of

Peregrine Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock par value $0.0001 per share

(Title of Class of Securities)


(CUSIP Number)

July 11, 2017

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)

* The remainder of
this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover

The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Follow Avid Bioservices Inc. (NASDAQ:CDMO)

Page 1 of 5